Biocryst director receives stock retainer
Stonehouse Jon P reported acquisition or exercise transactions in this Form 4 filing.
Rhea-AI Filing Summary
Stonehouse Jon P reported acquisition or exercise transactions in this Form 4 filing.
BIOCRYST PHARMACEUTICALS INC director Jon P. Stonehouse reported receiving 631 shares of Common Stock on May 29, 2026. These shares were issued in lieu of 50% of his quarterly Board member cash retainer of $11,250 at a price of $8.91 per share.
After this stock-based retainer, Stonehouse directly holds 1,324,481 shares of Common Stock. The filing also lists 40,000 shares held in the Samuel Stonehouse Irrevocable Trust and 40,000 shares in the Caroline Stonehouse Irrevocable Trust, reported as indirect ownership through his wife as co‑trustee.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 631 shares
Grant/Award
3 txns
Insider
Stonehouse Jon P
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 631 | $8.91 | $6K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 1,324,481 shares (Direct);
Common Stock — 40,000 shares (Indirect, By wife as co-trustee of the Caroline Stonehouse Irrevocable Trust);
Common Stock — 40,000 shares (Indirect, By wife as co-trustee of the Samuel Stonehouse Irrevocable Trust)
Footnotes (1)
- F1. Shares of Common Stock issued to the reporting person in lieu of 50% of the quarterly cash Board Member retainer of $11,250.
Key Figures
Shares granted: 631 shares
Grant price: $8.91 per share
Cash retainer reference: $11,250
+3 more
6 metrics
Shares granted
631 shares
Common Stock grant on May 29, 2026
Grant price
$8.91 per share
Value used for stock retainer in lieu of cash
Cash retainer reference
$11,250
Quarterly Board Member cash retainer, 50% taken in stock
Direct holdings after grant
1,324,481 shares
Common Stock directly held by Jon P. Stonehouse
Samuel Trust holdings
40,000 shares
Indirect ownership via Samuel Stonehouse Irrevocable Trust
Caroline Trust holdings
40,000 shares
Indirect ownership via Caroline Stonehouse Irrevocable Trust
Key Terms
Form 4, Grant, award, or other acquisition, quarterly cash Board Member retainer, indirect ownership, +1 more
5 terms
Form 4 regulatory
"INSIDER FILING DATA (Form 4):"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
Grant, award, or other acquisition financial
"transaction_code_description: "Grant, award, or other acquisition""
quarterly cash Board Member retainer financial
"in lieu of 50% of the quarterly cash Board Member retainer of $11,250"
indirect ownership financial
"ownership_type: "indirect", ownership_code: "I""
Common Stock financial
"security_title: "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Biocryst (BCRX) director Jon Stonehouse report in this Form 4?
Jon P. Stonehouse reported receiving 631 shares of Biocryst Common Stock. The shares were issued as stock compensation in place of half of his quarterly Board cash retainer of $11,250, at a price of $8.91 per share.
Was the Biocryst (BCRX) Form 4 transaction a market purchase or sale?
The Form 4 reports a grant or award acquisition, not a market trade. Shares were issued to Jon P. Stonehouse as compensation in lieu of a portion of his quarterly Board cash retainer, at a stated value of $8.91 per share.
What indirect Biocryst (BCRX) holdings are reported for Jon Stonehouse?
The Form 4 lists 40,000 Biocryst shares in the Samuel Stonehouse Irrevocable Trust and 40,000 in the Caroline Stonehouse Irrevocable Trust. These are reported as indirect ownership, held by his wife as co‑trustee of each trust.
AI-generated analysis. How Rhea-AI works. Not financial advice.
